Our neurologists routinely lead and participate in CMT research and provide patients with access to the latest evidence-based therapies and most promising clinical trials. Dr. Thomas is currently leading multiple U.S. centers in two international clinical trials to study novel treatments for CMT disease.
At the 71st American Academy of Neurology Annual Meeting in Philadelphia in May 2019, Dr. Thomas was recognized for two abstracts: “Efficacy and Safety of PXT3003 in Patients With Charcot-Marie-Tooth Type 1A: Results of PLEO-CMT, an International Pivotal Phase 3 Trial” and “Results of the Dose Escalation Portion of a Phase 2 Study of ACE-083, a Local Muscle Therapeutic, in Patients With Charcot-Marie-Tooth Disease.”
Meet Our Team
|Florian P. Thomas, M.D., M.A., Ph.D., M.S.
|Wayne Berberian, M.D.
Foot and Ankle Surgeon